Literature DB >> 15893122

Is autism caused by early hyperactivity of brain-derived neurotrophic factor?

Shih-Jen Tsai1.   

Abstract

Autism, a childhood-onset neurodevelopmental disorder, is characterized by disturbances in socialization and language skills, as well as in perception. Several studies indicate the importance of both genetic and environmental factors in the development of idiopathic autism, but the underlying pathogenesis of this disorder is still unknown. Brain-derived neurotrophic factor (BDNF) is important for normal neuronal development. Early BDNF hyperactivity may play an etiological role in autism early in life. This hypothesis is supported by the finding that serum and brain tissue BDNF levels are increased in autism compared with normal controls. Furthermore, BDNF hyperactivity may be associated with early brain outgrowth, increased prevalence of seizures in autism, and similar behaviors observed in autism and fragile X syndrome. Further studies of serum BDNF levels and genetic studies of the BDNF signaling pathway may help to clarify the role of BDNF in the pathogenesis of autism. Attempts to prove the BDNF hyperactivity hypothesis may lead investigators in a new direction for the study of the pathogenesis of autism and the development of an effective intervention of this disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893122     DOI: 10.1016/j.mehy.2005.01.034

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  21 in total

1.  Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.

Authors:  Lindsay Oberman; Mark Eldaief; Shirley Fecteau; Fritz Ifert-Miller; Jose Maria Tormos; Alvaro Pascual-Leone
Journal:  Eur J Neurosci       Date:  2012-06-28       Impact factor: 3.386

2.  Brief report: enhanced picture naming in autism.

Authors:  Matthew Walenski; Stewart H Mostofsky; Jennifer C Gidley-Larson; Michael T Ullman
Journal:  J Autism Dev Disord       Date:  2007-12-27

3.  TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice.

Authors:  Pavel A Kipnis; Brennan J Sullivan; Brandon M Carter; Shilpa D Kadam
Journal:  JCI Insight       Date:  2020-06-18

4.  Early generalized overgrowth in boys with autism.

Authors:  Katarzyna Chawarska; Daniel Campbell; Lisha Chen; Frederick Shic; Ami Klin; Joseph Chang
Journal:  Arch Gen Psychiatry       Date:  2011-10

5.  Increased BDNF expression in fetal brain in the valproic acid model of autism.

Authors:  Luis E F Almeida; Clinton D Roby; Bruce K Krueger
Journal:  Mol Cell Neurosci       Date:  2014-01-28       Impact factor: 4.314

6.  Meta-Analysis of BDNF Levels in Autism.

Authors:  Raluca Armeanu; Mikael Mokkonen; Bernard Crespi
Journal:  Cell Mol Neurobiol       Date:  2016-08-08       Impact factor: 5.046

7.  Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study.

Authors:  Lisa A Croen; Paula Goines; Daniel Braunschweig; Robert Yolken; Cathleen K Yoshida; Judith K Grether; Bruce Fireman; Martin Kharrazi; Robin L Hansen; Judy Van de Water
Journal:  Autism Res       Date:  2008-04       Impact factor: 5.216

8.  Sera from children with autism alter proliferation of human neuronal progenitor cells exposed to oxidation.

Authors:  Bozena Mazur-Kolecka; Ira L Cohen; Edmund C Jenkins; Michael Flory; George Merz; W Ted Brown; Janusz Frackowiak
Journal:  Neurotox Res       Date:  2009-04-18       Impact factor: 3.911

9.  A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism.

Authors:  Antonio Y Hardan; Robin A Libove; Matcheri S Keshavan; Nadine M Melhem; Nancy J Minshew
Journal:  Biol Psychiatry       Date:  2009-06-11       Impact factor: 13.382

10.  Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker.

Authors:  Balmiki Ray; Justin M Long; Deborah K Sokol; Debomoy K Lahiri
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.